Introduction
Community acquired bacterial meningitis is a life threatening infection of the leptomeninges often related with serious complication and sequelae. Low and middle-income countries account for 98% of the estimated 5.6 million disability-adjusted life years attributed to meningitis globally. In high-income countries, bacterial meningitis ranks among the top ten causes of death in children younger than 14 years of age [1] . Primary prevention of meningitis using vaccines is paramount, since death and long-term disabling sequelae are substantial in all settings especially those with least access to health care [2] . Bacterial meningitis accounts for approximately 6-8% of hospital admissions in Ethiopia with a case fatality rate of as high as 22-28 [3] . The most common pathogens being S. pneumonia, N.
meningitides and H.influenzea [4] [5] [6] . During the last several decades disease epidemiology and clinical features has changed dramatically in the countries that adapted the conjugate vaccines against H.
influenza type b and S. pneumoniae [7] [8] [9] [10] [11] . In Ethiopia the 
Methods
This retrospective study was conducted at Gondar University Hospital (GUH). Gondar is a city located in the North West Ethiopia, which is in the sub-Saharan meningitis belt. Most of the patients come from Gondar, but also receives patients from the adjoining regions of Amhara Regional State. The Gondar University Hospital is the largest hospital in Gondar. It is a 400-bed teaching hospital associated with a medical college. The department of pediatrics and child health has 5 different wards the main pediatric main ward has 46 beds and provides inpatient care for children < 14 years of age.
All admissions and discharges to the pediatric main ward were reviewed over a 2 years period from September, 2011 through 
Results
Over the past two years 80 children were discharged with the diagnosis of CABM. During this time there were 4994 admissions, giving an admission rate for CABM 1.6% during the study period. A peak admission rate was registered during the month of March (n=18, 22.5%) followed by February (n = 12, 15%) coinciding with the dry season. Bacterial meningitis was more common in children under one year (40%), and most patients were male (65%).
Distribution of residence was slightly higher among urban and rural areas (53% vs 47%). Other demographic and clinical characteristics are shown in Table 1 . Possible predisposing factors for meningitis were upper respiratory traction infection (25%), lack of breastfeeding (10%), previous admission (10%), lack of immunization (10%) and malnutrition of both moderate and severe in 2.5%. Of the children who werenot vaccinated or partially vaccinated, 4(50%) of them were infants and the rest are above one year of age. Only 12 (15%) of patients were admitted to our hospital within 24 hour of the onset of symptoms, the majority presented after 24 hours but within 72 hours (n = 34, 42.5%) or after 72 hours (n = 34, 42.5%). Among those admitted 22 (27.5%) received some form of antibiotics in local health centers The most common clinical manifestations for each age group are shown in Table 2 . Almost all patients (n = 78, 97.5%) had CSF examination done immediately after admission, the results are shown in Table 2 .
Moderate pleocytosis (>1000cells/mm 3 ) was found in 20% of children, the majority of the patients (75%) had cell count between 100-1000, cells/mm 3 with a neutrophil predominance (70-98%).
Hypoglycorrhea and elevated protein level was fond in 42.5%. Of 80 patients diagnosed with CABM, 20 (25%) of cases had culture confirmed ABM, S. pneumoniae was isolated in 14/20 (70%) and H.
influenzea in 4/20 (20%) of the cases.
Age related clinical and laboratory features of bacterial meningitis are shown in Table 2 and Table 3 . There is no specific sign or symptom which can predict culture positivity as it's shown on analysis of symptoms versus the culture positivity rate Table 4 . The majority of patients (n = 50, 62.5%) were treated with ceftriaxone and the rest with a combination of penicillin and chloramphenicol (n = 30, 37.5%). Just more than half of the patients (52.5%) were treated for 10 days and 28(35%) of them were treated for 14 days.
Dexamethasone was given for 56(70%) patients before the antibiotics or at the same time. Most patients (n=68, 85%) were discharged improved and the rest (n = 12, 15%) were discharged with sequelae, died or disappeared. Overall case fatality was 7.5% (6/80) and all the deaths were due to S.pneumoniae which gives a case fatality rate for this organism of 42.8%. All of the children who died were above the age of 10 years (P < 0.05). Prolonged fever is found to be more prevalent among children under five years followed by infants and older than 10 years (p = 0.36). Seizure after 72 hrs of admission was a common complication among children older than 10 years old (p = 0.283).
Different factors contributed for poor outcome in this study as it is shown on Table 5 . Neurologic sequelae (focal neurologic deficit, depressed consciousness) at discharge was associated with young 
Discussion
The hot, dry seasonal increase in admission and male predominance was consistent with other studies from Bangladesh [13] and BurkinaFaso [14] ; but not similar to previous studies from Gondar [4] and Addis Abeba [3] . The preponderance of the under-fives underscores the age group that bears the brunt of the disease burden. Clinical features that are found to be dominant in our study are also found in the previous studies done in the pre PVC period suggesting that there is no significant change in the clinical pneumoniae is still the most common organism isolated from the culture accounting for the 70% [4, 17] . Part of this may be explained by the fact most cases of pneumococcal meningitis was seen in children older than 10 years, and those who were partially immunized or unimmunized. Finally, other strains not contained by the vaccine could be the pathogen. Literature in the pre PVC-10 period indicates that CABM is associated with a high risk of neurological complications, with a percentage of up to 38%, and mortality rates up to 18% [17] [18] [19] [20] . In the present study, this frequency was 5% for the complication and mortality rate was 7.5%, which is significantly lower than seen in previous studies.
In previous studies loss of consciousness, focal neurologic deficit, seizure at admission, delayed presentation and S. pneumoniae were found to be risk factors for poor outcome [19] [20] [21] [22] [23] . In the present study, the presence of seizure at admission, loss of consciousness, culture positivity and focal neurologic deficit were associated with poor outcome which was in agreement to these previous studies.
However, use of dexamethasone and delayed presentation was not found to be a predictor of poor outcome in this study. Antibiotics of choice were found to have a strong association with death in the present study. This may reflect an increase in possible resistant strains in the community but it needs a laboratory baser surveillance study for to make conclusion. While third generation cephalosporins such as ceftriaxone are the first line treatment for CABM in our setting, it may not be available due to stock outs, resulting in health care providers using older treatment recommendations from WHO such as penicillin and chloramphenicol. The study was retrospective in design and subject to the potential biases of retrospective reviews. However, we collected objective clinical and laboratory features that should be reliably recorded in the medical record. The medical records also had limited data about the study patient's PCV-10 immunization status. Although overall immunization was high in the study we cannot exclude the possibility that some of our study patients were either unimmunized or under immunized with PCV-10.
The other limitation was the subjectivity of discharge conditions has created some difficulties in finding the exact outcome, especially of neurologic outcomes. Another limitation was the paucity of data regarding antibiotics susceptibility patterns, since laboratory reports were incomplete. Finally, this study had only 20% culture positive specimens, though this would result in an overestimation of CABM.
The limited availability of culture reflects many resource-constrained setting, and we believe by applying WHO criteria for the definition of CABM gives us a reasonable estimate of the burden of CABM in our community.
Conclusion
Based on the results of this study, we can conclude that introduction of PCV-10 and Hib to the immunization schedule has decreased the admission rate, mortality, and morbidity of CABM among children under 5 years old. It is also possible to conclude from this study that loss of consciousness, seizure at admission and focal neurologic deficit at admission predictors of adverse outcomes at admission and hence these patients needs proper evaluations and meticulous follow up in the ward as well as after discharge.
What is known about this topic 
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